MATR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.14919970709104E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.63619999952125E-07 |
Normal-vs-Stage2 |
2.156800E-03 |
Normal-vs-Stage3 |
3.47220030505468E-10 |
Normal-vs-Stage4 |
7.06057434740615E-12 |
Stage1-vs-Stage2 |
9.270000E-01 |
Stage1-vs-Stage3 |
3.336600E-03 |
Stage1-vs-Stage4 |
1.380500E-03 |
Stage2-vs-Stage3 |
1.322630E-01 |
Stage2-vs-Stage4 |
7.068400E-02 |
Stage3-vs-Stage4 |
6.447600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.28220023277015E-10 |
Normal-vs-AfricanAmerican |
8.38799996127904E-09 |
Normal-vs-Asian |
1.728440E-02 |
Caucasian-vs-AfricanAmerican |
2.504800E-01 |
Caucasian-vs-Asian |
9.627000E-01 |
AfricanAmerican-vs-Asian |
6.407200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.71449973610061E-10 |
Normal-vs-Female |
2.33810000027646E-07 |
Male-vs-Female |
1.050030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.1718000000327E-06 |
Normal-vs-Age(41-60Yrs) |
4.14819999461358E-08 |
Normal-vs-Age(61-80Yrs) |
1.87969972920143E-10 |
Normal-vs-Age(81-100Yrs) |
7.62120000000754E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.494550E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.813800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.343400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.933600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.153400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.876000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.771230E-01 |
Normal-vs-Grade 2 |
5.74559999999558E-05 |
Normal-vs-Grade 3 |
1.73683289972359E-12 |
Normal-vs-Grade 4 |
1.65822910958013E-12 |
Grade 1-vs-Grade 2 |
5.384800E-01 |
Grade 1-vs-Grade 3 |
1.579680E-02 |
Grade 1-vs-Grade 4 |
1.042690E-03 |
Grade 2-vs-Grade 3 |
2.390400E-04 |
Grade 2-vs-Grade 4 |
2.26259999958067E-07 |
Grade 3-vs-Grade 4 |
4.198500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.319660E-03 |
Normal-vs-ccB subtype |
3.47522011168167E-12 |
ccA subtype-vs-ccB subtype |
7.685500003074E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.72119995823073E-09 |
Normal-vs-N1 |
2.49610000002676E-06 |
N0-vs-N1 |
1.159200E-01 |
|
|